-- Days : -- HRS : -- MIN : -- SEC

Register for Free →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Alan Bakst, PharmD, MBA

Articles by Alan Bakst, PharmD, MBA

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study

ByWilliam H. Herman, MD, MPH,Riad G. Dirani, PhD,Ruslan Horblyuk, MBA,M. Colleen O'Neill, BSc,Barbara Kravitz, MS,Mark A. Heise, PhD,Alan Bakst, PharmD, MBA,Martin I. Freed, MD,the RESULT St

April 1st 2005

Latest Updated Articles

Reduction in Use of Healthcare Services With Combination Sulfonylurea and Rosiglitazone: Findings From the Rosiglitazone Early vs SULfonylurea Titration (RESULT) Study
April 1st 2005

Trending on AJMC

Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%

Real-World AMKD Data Highlight Quick Progression, Unmet Needs

Insurance Barriers Tied to Missed Long-Acting PrEP Starts

IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness

Former USAID Health Chief Says Aid Cuts Are Costing Children's Lives